Article | April 12, 2024

EMA'S eCTD 4.0 Workshop Seeks To Gear Industry For Implementation

By Karl-Heinz Loebel, Director & Principal Consultant Of Regulatory Operations, Cencora PharmaLex

GettyImages-1467006387 doctor at computer

The European Medicines Agency (EMA) is getting ready to implement the eCTD 4.0 standard in the pharmaceutical industry. In this article, we will explore the key developments, including the recently released draft EU eCTD 4.0 Implementation Guide and the upcoming pilot programs.

The new guide, together with the ICH eCTD 4.0 V1.5 Implementation Guide, explains the structure and functionalities of eCTD 4.0. The guide primarily focuses on Centralized Procedure (CP) submissions to EMA, with a plan to roll it out for national agencies later. To ensure a smooth transition, EMA conducted a workshop in March to address potential gaps and gather industry feedback. A key theme that emerged is the need for clarity on document replacement, reuse, and the use of dedicated eCTD 4.0 review tools.

This article outlines the planned eCTD 4.0 implementation timeline, including voluntary technical and business pilot programs that are expected to begin this year. Industry participants are encouraged to familiarize themselves with the new standard and consider participating in the pilot programs.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Clinical Leader